SCHEMBL22096841

SCHEMBL22096841

CONC(=O)Nc1c(F)cccc1C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
KDR P35968 2/20 0.40
PDE4D Q08499 2/20 0.40
PDGFRA P16234 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
NLRP3 Q96P20 2/20 0.39
LPAR1 Q92633 1/20 0.39
NR1I2 O75469 1/20 0.38
CYP2C8 P10632 1/20 0.38
IDO1 P14902 1/20 0.38
TEK Q02763 1/20 0.38
P2RY1 P47900 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096846 0.83 NLRP3 (0.47) ALDH1A1KMT2APDE4DCA2NLRP3
SCHEMBL19782074 0.80 ATM (0.49) ALDH1A1KMT2APDE4DCA12CA1
SCHEMBL22096827 0.79 KMT2A (0.37) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL22096896 0.78 PDE4A (0.37) ALDH1A1PDE4DLPAR1P2RY1PDE4A
SCHEMBL23491343 0.78 CACNA1C (0.48) ALDH1A1KMT2APDE4DCA12CA1
SCHEMBL22096863 0.77 KMT2A (0.42) ALDH1A1KMT2APDE4DNLRP3RAB9A
SCHEMBL19779545 0.77 LPAR1 (0.53) ALDH1A1KMT2ALPAR1SMN1; SMN2KDM4E
SCHEMBL22096823 0.74 GPR35 (0.37) ALDH1A1
SCHEMBL22096821 0.72 RAB9A (0.47) ALDH1A1KMT2AP2RY1RAB9ANPC1
SCHEMBL22096802 0.71 POLB (0.51) ALDH1A1KMT2ARAB9APKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875839-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-12-29 US disclosed
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ALDH1A1 4626/4885KMT2A 4607/4885KDR 1432/4885
US-10875839-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ALDH1A1 4626/4885KMT2A 4607/4885KDR 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.